Stomach in Biological Technology

Surgeons Perform First Incisionless Bariatric Procedure in the United States

... the mouth and then used EOS tools to grasp the stomach tissue and deploy suture anchors to create multiple tissue folds in the stomach wall to reduce its capacity. "Bariatric ... appealed to her because it would reshape her stomach and help her to feel full earlier when eating, ...

FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD

... opens to allow food and liquids to enter the stomach and closes to keep acid and food in the stomach. ... as it should, or relaxes too often, it can cause stomach contents to get into the esophagus repeatedly. The stomach is better equipped to handle acid than the ...

Probiotic Delivery Technology Awarded Third International Patent

... ingredients like probiotic organisms from stomach acid on their way to optimal release sites in ... shelf -- Safe passage through the harsh stomach acids that may denature the organisms ... conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the ...

JCI table of contents: April 22, 2008

... inflammation and tumor development in the stomach Persistent infection with the bacterium ... pylori leads to persistent inflammation of the stomach lining and in some individuals stomach cancer, also known as gastric cancer. New insight ...

Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic

... that can survive transit through the harsh stomach environment. "Sustenex is a great choice because ... protective shell that shields the bacteria from stomach acid as it moves through your digestive system. ... struggle to make it though the harsh, acidic stomach environment. Probiotics like Bacillus coagulans ...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

... dependence that involves ghrelin. Ghrelin is a hormone produced by the stomach and acting in the brain. Compelling evidence obtained with the ... Program Ghrelin is a natural peptide hormone produced by the stomach that increases appetite and induces accumulation of fat tissue. The ...

Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock

... survives pelleting and other manufacturing processes as well as the harsh stomach environment of the animal. GanPro delivers consistent results, is ... allows the bacteria to survive harsh manufacturing processes and the stomach environments of the animals to reach their digestive tract where they can ...

China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules

... for the relief of drug-induced liver injury. However, this drug can cause stomach irritation therefore its use and patient compliance may be limited by the ... has developed Tiopronin Capsules with an enteric coating to decrease the stomach mucosal irritation associated with Tiopronin. As a result, China Pharma's ...

Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals

... is well tolerated but may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who take Aricept(R) ...

U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing

... is well-tolerated, but may not be for everyone. People at risk for stomach ulcers or who take certain other medications should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who take Aricept(R) ...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

... be delivered orally with the LPM(TM) system include various classes of drugs such as peptides, nucleic acids and proteins which are degraded in the stomach and small intestine. Corresponding patents in the United States and elsewhere are currently pending. About DOR BioPharma, Inc. DOR ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To ...

Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology

... currently found in popular yogurt brands, Ganeden BC30 (R) is able to survive the heat and pressure of manufacturing processes, as well as the acidic stomach environment. The protection of the bacteria by a naturally-occurring hardened shell of organic material accounts for the strains viability and ...

Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

... due to the drug's strict every-six hour dosing schedule and dose-limiting side effects, including gastrointestinal ("GI") problems such as stomach aches, nausea and vomiting. Patrice Rioux, M.D., Ph.D., Raptor's Chief Medical Officer stated, "We are pleased that enrollment is now underway ...

AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use

... prostaglandins throughout the body and as a consequence, ongoing inflammation, pain and fever are reduced. Since the prostaglandins that protect the stomach are reduced, NSAIDs often cause ulcers in the stomach. It is estimated that GI hemorrhages due to NSAID use account for approximately 60,000-120,000 ...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... in combination with cisplatin, another chemotherapy drug, are low blood cell counts (red blood cells, white blood cells, and platelets); tiredness; stomach upset, including nausea, vomiting, and diarrhea; mouth, throat, or lip sores; loss of appetite; rash; and constipation. Call your healthcare ...

Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis

... EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. Gastroparesis is a syndrome characterized by delayed emptying of the stomach into the intestine following a meal in the absence of mechanical obstruction. Diabetes is an important cause of gastroparesis, but other identified ...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To ...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To ...

FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

... than or equal to 5% of patients, included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, and stomach discomfort. Particular care is needed for patients being transferred from systemically active corticosteroids to inhaled corticosteroids. ...

Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum

... to the latest nanoliposomal technology, which wraps the active agents in a protective envelop. Until this delivery technology was available, stomach acid would inactivate and destroy the active agents responsible for the increase in growth hormone production. Prior to Secretropin(R), this ...

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

... between prolactin levels and side effects is unknown. People with narrowing or blockage of the gastrointestinal tract (esophagus, stomach or small or large intestine) should talk to their healthcare professional before taking paliperidone. Some people taking paliperidone may ...

UCF professor develops vaccine to protect against black plague bioterror attack

... the outside of Yersinia pestis. The vaccine was inside the plant cells, which were given to the rats. The vaccine was protected from digestion in the stomach and was then absorbed in the gut. It kick started the immune system into producing antibodies, which protects against the deadly disease. Three to ...

China-Biotics, Inc. Reports Second Quarter 2009 Financial Results

... from an increase in the number of the Company's Shining retail outlets to 110 from 22 the prior year. New products, including Shining Essence stomach Protection Capsules, Shining Probiotics Protein Powder and other products accounted for 16.3% of total sales during the quarter, up from a combined ....

Lixte Biotechnology Holdings Announces New Appointment to Board of Directors

... neuroblastoma, and pancreatic cancer in animal models of these diseases and is also active against breast, colon, lung, prostate, ovary, stomach and liver cancer and the major types of leukemias in cell culture. Forward-Looking Statements This announcement contains certain forward-looking ...

UCF professor develops vaccine to protect against black plague bioterror attack

... the outside of Yersinia pestis. The vaccine was inside the plant cells, which were given to the rats. The vaccine was protected from digestion in the stomach and was then absorbed in the gut. It kick started the immune system into producing antibodies, which protects against the deadly disease. Three to ...

Spherics, Inc. Offers Once Daily Extended Release Formulation for Sustained and Stable Pramipexole Delivery

... motor fluctuations and GI and CNS AE's) and compliance issues (3x daily dosing). SRx-503 maintains a more stable release profile, bypasses the stomach to alleviate GI side effects and requires dosing only once daily. Persons interested in bidding must sign a Confidentiality Agreement ("CA") ...

Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)

... temporary. RAZADYNE(R) and RAZADYNE(R) ER may not be for everyone. Some people experience a slowed heart rate, which may lead to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers. Please ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... tumors (GIST) belong to a group of cancers known as soft tissue sarcomas. They are the most common sarcomas and can be found most often in the stomach and small intestine. The incidence of GIST is estimated to be 4,500 - 6,000 new cases per year in the US (15-20 cases per million population)(5), of ...

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA

... requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To reduce ...

RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer

... system, thus avoiding Cox 1 inhibition, the major cause of gastrointestinal problems. Additionally, its microparticle coating protects the stomach and intestinal lining from direct contact with the aspirin. Asacard(R) is currently approved for marketing in 11 countries including France and the ...

China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base

... It has a portfolio of more than 60 medicines and supplements, one of which is Chang Wei Ning Capsule, a probiotics-based medicine used to improve stomach and intestinal health. "Square Pharmaceutical marks our fifth bulk additives customer, all of which have signed contracts before we begin ...

China-Biotics, Inc. Reports First Quarter 2009 Financial Results

... from growth in the sales volume of new products and increases in the sales price of selected products. These new products, including Shining Essence stomach Protection Capsules and Shining Probiotics Protein Powder, accounted for 16.6% of total sales during the quarter, up from 5.0% a year ago. Sales of ...

Horizon Therapeutics Announces Corporate Relocation to the Chicago Area

... ibuprofen combined with famotidine in a single pill currently in Phase 3 clinical trials. Because approximately 25 percent of NSAID users may develop stomach ulcers, HZT-501 may offer patients effective pain relief with the confidence of GI-protection. Horizon expects to have data from the HZT-501 Phase 3 ...

Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP

... headache, stomach pain, nausea, vomiting, and numbness or tingling of the skin. Less common adverse effects include abnormal muscle movements, severe stomach cramps, severe nausea or vomiting, bloody stools, severe diarrhea, decreased urination, vaginal irritation or discharge, fever, white patches in ...

Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP

... rash; bruising; severe tingling; numbness; pain; muscle weakness; injection site pain, swelling or irritation; heartburn; bloating; and severe upper stomach pain. About Cefuroxime Cefuroxime for injection, USP, is a semisynthetic broad spectrum antibiotic agent for parenteral administration used to ...

AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test

... of 91% and a specificity of 93% in testing conducted on patients with hepatocellular, cholangiocellular, pancreatic, colorectal, stomach and oesophagus cancers. -- The test reliably differs between patients with cancer of the gastrointestinal tract or the hepatobilary system and ...

FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents

... well-established safety profile. The most common side effect possibly related to ACIPHEX is headache. Symptom relief does not rule out other serious stomach conditions. Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and ...

Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass

... early clinical experience (poster 102, June 18), Daniel Herron, MD, and colleagues used the EOS to create tissue folds around the stoma and in the stomach pouch of eight patients with an average of four pairs of expandable tissue anchors. No major complications occurred and the only minor complications ...

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

... requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney. When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To reduce ...